Net profit of Marksans Pharma rose 29.26% to Rs 88.75 crore in the quarter ended June 2024 as against Rs 68.66 crore during the previous quarter ended June 2023. Sales rose 18.12% to Rs 590.62 crore in the quarter ended June 2024 as against Rs 500.03 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
| Sales | 590.62 | 500.03 | 18 |
| OPM % | 21.75 | 20.39 | - |
| PBDT | 140.46 | 110.49 | 27 |
| PBT | 120.02 | 96.83 | 24 |
| NP | 88.75 | 68.66 | 29 |